glp-1 news 2025 november 25 Pipeline Update: - Prime Therapeutics GLP-1 trends 2025: real-world data,
Description
Dive into the history and overview of GLP-1s in our 2-minute video.
For people who stopped taking GLP-1 weight-loss medications, patients regained about 60% of the weight []
NAION = non-arteritic anterior ischemic optic neuropathy is a rare cause of blindness and has been reported at higher rates in those taking GLP1s
Dope Doctors offers personalized care, convenient telehealth, and expert guidance.
Access up-to-date information on glucoregulatory hormones and GLP-1/GIP receptor agonists with clinical guidance at Healio.
Novo Nordisk's Wegovy pill expands obesity drug market Novo Nordisk's oral GLP-1 treatment, the Wegovy pill, has seen high demand since its January launch, attracting patients who previously avoided injections due to needle fear or high costs
